Thu, Dec 18, 2014, 8:48 AM EST - U.S. Markets open in 42 mins.

Recent

% | $
Quotes you view appear here for quick access.

Rockwell Medical, Inc. Message Board

  • avramj98 avramj98 May 14, 2013 11:13 AM Flag

    RMTI and NXTM

    Just curious here. What do you shareholders think of RMTI being acquired by NXTM? What would it take pricewise? I am a NXTM shareholder and have tracked RMTI for over 3 years and think the fit would be good. Not to rain on RMTI's party, but even if they get approval of Calcitrol, they would be entering into a very competitive market with a limited sales force. Joining with NXTM puts the combined co. in a better position to be profitable, grow (NXTM now has a significant footprint in Europe as well as hospitals and the home dialysis market), and would become a more desirable takeover target.

    Serious responses are respectfully requested.

    AJ

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Agree marketing/sales is a RMTI's weakness. They couldn't even capitalize on the Fresenius Class I recall in March 2012. Remember all that talk about the Fresenius recall maybe doubling RMTI sales? RMTI's 2012 sales were down 16% from their high point in 2010. First QTR 2013 down 5% from 4th QTR 2012. Sales for the last half of 2012 should have been going thru the roof. For whatever reason RMTI couldn't capitalize.

      Now think about this, is the existing RMTI sales/marketing team the one we want going up against real marketing pros with actual experience selling drugs? I hope I'm wrong, but I don't see RMTI winning against real pros. If anything Calcitrol will just cause price reductions in other products. Most likely all Davita will do is use Calcitrol to obtain a price reduction from their current vendors . That way nothing changes in center except better pricing for a product they are already experienced with. Not a bad thing for the providers.

      IMHO, no way NXTM will pay anything for RMTI now. Beyond manufacturing concentrate, NXTM has no need for RMTI. An established drug company is the only one who would pay for RMTI at this point, IMHO.

 
RMTI
8.32+0.04(+0.48%)Dec 17 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Accenture plc
NYSEWed, Dec 17, 2014 4:00 PM EST
Volcano Corporation
NasdaqGSWed, Dec 17, 2014 4:00 PM EST